January 8, 2025
Athagoras Acquires Quantify Research to Enhance Real-World Evidence and Market Access Capabilities
Munich, January 8th, 2025 – Athagoras, a leading specialized life science consulting group, today announced the acquisition of Quantify Research, a Nordic-headquartered specialist in real-world evidence (RWE) and market access. The acquisition expands Athagoras' global capabilities, adding a leading presence in the Nordic countries and strategic reach into Asia-Pacific. Founded in 2011, Quantify Research serves nineteen of the top twenty global pharmaceutical companies through three core practice areas: Real-World Evidence and Analytics (RWEA), Modelling, Access & Strategy (MAS), and Evidence Review & Synthesis (ERS). The company provides end-to-end scientific services, leveraging Nordic real-world data covering over 150 million patient-years. Internationally recognised for its high quality, this data is increasingly utilised by payers and regulators in both the EU and U.S.
Strategic Rationale
The acquisition combines Quantify's Nordic market leadership with Athagoras' strategy, creating a stronger platform to serve clients worldwide. In particular, the U.S. market’s demand for high-quality RWE and value demonstration continues to grow. Athagoras will leverage its expanded capabilities to drive innovation and value across its portfolio.
Dr. Roman-Marcus Rittweger, CEO of Athagoras, stated: "The acquisition of Quantify Research marks a significant step in our strategy to build a leading global lifescience consulting group. Quantify's expertise in real-world evidence and market access complements our existing capabilities, enhancing our ability to support the life science industry and navigate the complex access landscape. We welcome the Quantify team to the Athagoras family as we work together to shape the future of market access."
"This partnership accelerates our international expansion and strengthens our ability to deliver comprehensive real-world evidence and market access solutions to clients," said Dr. Kirk Geale, CEO of Quantify Research. “By joining forces with Athagoras, we can leverage our unique Nordic data assets and market access expertise across a global platform, creating new opportunities for life science companies worldwide and continuing our mission to enable patient-centric healthcare."
Future Outlook
Athagoras will drive growth and innovation by expanding the scope of Quantify’s unique evidence solutions and creating synergies across its current and future portfolio companies. This acquisition strengthens Athagoras’ progress towards becoming the European leader in life science consulting, offering unparalleled expertise and data-driven insights to life science companies worldwide. The expanded platform is well positioned for future growth and the delivery of innovative solutions that drive value for clients.
About ATHAGORAS
Athagoras is building a group of leading service providers to create a tech-enabled European specialist service provider for the clinical and commercial development of healthcare innovations in the pharmaceutical & biotech industry within regulatory affairs, pharmacovigilance, as well as market access and real-world evidence. For more information, please visit the about us page.
About Quantify Research
Quantify Research is a leading global partner in real-world evidence generation, health economics & outcomes research (HEOR), market access strategy and economic modelling. Quantify provides scientific and commercialization services to the life science industry including the world’s largest pharmaceutical companies. Quantify Research is proud to have a broad collaborative network with stakeholders including academic institutions, governmental authorities, and patient groups. Through its experience, domain expertise and broad range of capabilities, Quantify Research offers solutions and insights to help the life science industry improve patient lives.
